Qube Research & Technologies Ltd - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$72
-99.8%
52
-99.8%
0.00%
Q3 2022$46,000
-37.0%
29,996
-9.2%
0.00%
-100.0%
Q2 2022$73,000
-28.4%
33,038
+115.4%
0.00%0.0%
Q2 2021$102,000
-81.9%
15,335
-74.7%
0.00%
-88.9%
Q1 2021$562,000
-67.6%
60,647
-37.1%
0.01%
-64.0%
Q4 2020$1,735,00096,4450.02%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 2,522,083$15,158,00012.39%
Octagon Capital Advisors LP 982,753$5,906,0001.15%
Altium Capital Management LP 337,000$2,025,0000.56%
ACT CAPITAL MANAGEMENT, LLC 102,500$616,0000.44%
Eventide Asset Management 1,670,399$10,039,0000.13%
Artal Group S.A. 750,000$4,508,0000.12%
Aquatic Capital Management LLC 8,000$48,0000.09%
ELKHORN PARTNERS LIMITED PARTNERSHIP 17,300$104,0000.06%
Anson Funds Management LP 69,381$417,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 170,447$1,024,0000.02%
View complete list of CARDIFF ONCOLOGY INC shareholders